share_log

Chardan Capital Reiterates Buy on Senti Biosciences, Maintains $6 Price Target

Chardan Capital Reiterates Buy on Senti Biosciences, Maintains $6 Price Target

Chardan Capital重申買入Senti Biosciences,維持6美元的目標股價
Benzinga ·  2023/08/15 04:25

Chardan Capital analyst Geulah Livshits reiterates Senti Biosciences (NASDAQ:SNTI) with a Buy and maintains $6 price target.

Chardan Capital分析師Geulah Livshits重申了Senti Biosciences(納斯達克股票代碼:SNTI)的買入,並維持6美元的目標股價。

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論